171 related articles for article (PubMed ID: 10353732)
1. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.
Achiwa H; Yatabe Y; Hida T; Kuroishi T; Kozaki K; Nakamura S; Ogawa M; Sugiura T; Mitsudomi T; Takahashi T
Clin Cancer Res; 1999 May; 5(5):1001-5. PubMed ID: 10353732
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of COX-2 in the development of human lung cancers.
Takahashi T; Kozaki K; Yatabe Y; Achiwa H; Hida T
J Environ Pathol Toxicol Oncol; 2002; 21(2):177-81. PubMed ID: 12086404
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
Cho EI; Kowalski DP; Sasaki CT; Haffty BG
Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
[TBL] [Abstract][Full Text] [Related]
4. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients.
Santini D; Vincenzi B; Tonini G; Scarpa S; Vasaturo F; Malacrino C; Vecchio F; Borzomati D; Valeri S; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
Clin Cancer Res; 2005 May; 11(10):3784-9. PubMed ID: 15897577
[TBL] [Abstract][Full Text] [Related]
6. COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
Yamaguchi NH; Lichtenfels AJ; Demarchi LM; da Silva AP; Garippo AL; Alves VF; Michelin C; Azevedo PM; Moya T; Takagaki T; Saldiva PH; Vollmer RT; Capelozzi VL
Am J Clin Pathol; 2004 Jan; 121(1):78-86. PubMed ID: 14750244
[TBL] [Abstract][Full Text] [Related]
7. Survival in small cell lung cancer is independent of tumor expression of VEGF and COX-2.
Dowell JE; Amirkhan RH; Lai WS; Frawley WH; Minna JD
Anticancer Res; 2004; 24(4):2367-73. PubMed ID: 15330186
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomas.
Araki K; Hashimoto K; Ardyanto TD; Osaki M; Shomori K; Nakamura H; Ito H
Lung Cancer; 2004 Aug; 45(2):161-9. PubMed ID: 15246187
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth.
Lee JS; Choi YD; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Kim HS; Min KW
Gynecol Oncol; 2004 Dec; 95(3):523-9. PubMed ID: 15581957
[TBL] [Abstract][Full Text] [Related]
12. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.
Lim HY; Joo HJ; Choi JH; Yi JW; Yang MS; Cho DY; Kim HS; Nam DK; Lee KB; Kim HC
Clin Cancer Res; 2000 Feb; 6(2):519-25. PubMed ID: 10690533
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
[TBL] [Abstract][Full Text] [Related]
17. COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome.
Petersen S; Haroske G; Hellmich G; Ludwig K; Petersen C; Eicheler W
Anticancer Res; 2002; 22(2B):1225-30. PubMed ID: 12168930
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.
Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP
Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]